220 related articles for article (PubMed ID: 31445671)
1. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
Di J; Yang H; Jiang B; Wang Z; Ji J; Su X
Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743
[TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
4. Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing.
Han SW; Kim HP; Shin JY; Jeong EG; Lee WC; Lee KH; Won JK; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Seo JS; Kim JI; Kim TY
PLoS One; 2013; 8(5):e64271. PubMed ID: 23700467
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract][Full Text] [Related]
6. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
[TBL] [Abstract][Full Text] [Related]
7. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
[TBL] [Abstract][Full Text] [Related]
8. Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.
Sanz-Pamplona R; Lopez-Doriga A; Paré-Brunet L; Lázaro K; Bellido F; Alonso MH; Aussó S; Guinó E; Beltrán S; Castro-Giner F; Gut M; Sanjuan X; Closa A; Cordero D; Morón-Duran FD; Soriano A; Salazar R; Valle L; Moreno V
Clin Cancer Res; 2015 Oct; 21(20):4709-18. PubMed ID: 26071483
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
Escobar D; Bushara O; Sun L; Liao J; Yang GY
Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
[TBL] [Abstract][Full Text] [Related]
10. Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
Stahler A; Stintzing S; von Einem JC; Westphalen CB; Heinrich K; Krämer N; Michl M; Modest DP; von Weikersthal LF; Decker T; Kiani A; Heintges T; Kahl C; Kullmann F; Scheithauer W; Moehler M; Kaiser F; Kirchner T; Jung A; Heinemann V
Eur J Cancer; 2020 Sep; 137():250-259. PubMed ID: 32810748
[TBL] [Abstract][Full Text] [Related]
11. Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis.
Zhou D; Yang L; Zheng L; Ge W; Li D; Zhang Y; Hu X; Gao Z; Xu J; Huang Y; Hu H; Zhang H; Zhang H; Liu M; Yang H; Zheng L; Zheng S
PLoS One; 2013; 8(1):e53310. PubMed ID: 23301059
[TBL] [Abstract][Full Text] [Related]
12. Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.
Ashktorab H; Mokarram P; Azimi H; Olumi H; Varma S; Nickerson ML; Brim H
Oncotarget; 2017 Jan; 8(5):7852-7866. PubMed ID: 28002797
[TBL] [Abstract][Full Text] [Related]
13. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
[TBL] [Abstract][Full Text] [Related]
14. Clonality and heterogeneity of metachronous colorectal cancer.
Di J; Yang H; Wang Z; Yang J; Gao P; Jiang B; Su X
Mol Carcinog; 2019 Mar; 58(3):447-457. PubMed ID: 30499617
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
Chang YS; Lee CC; Ke TW; Chang CM; Chao DS; Huang HY; Chang JG
Cancer Med; 2019 Jul; 8(8):3738-3747. PubMed ID: 31127692
[TBL] [Abstract][Full Text] [Related]
16. New genetic variations discovered in KRAS wild-type cetuximab resistant chinese colorectal cancer patients.
Jing C; Wang T; Ma R; Cao H; Wang Z; Liu S; Chen D; Zhang J; Wu Y; Zhang Y; Wu J; Feng J
Mol Carcinog; 2020 May; 59(5):478-491. PubMed ID: 32141150
[TBL] [Abstract][Full Text] [Related]
17. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive somatic genome alterations of urachal carcinoma.
Lee S; Lee J; Sim SH; Lee Y; Moon KC; Lee C; Park WY; Kim NK; Lee SH; Lee H
J Med Genet; 2017 Aug; 54(8):572-578. PubMed ID: 28348108
[TBL] [Abstract][Full Text] [Related]
19. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
Bui VM; Mettling C; Jou J; Sun HS
BMC Med Genomics; 2020 Oct; 13(Suppl 10):149. PubMed ID: 33087131
[TBL] [Abstract][Full Text] [Related]
20. Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.
Shanmugam V; Ramanathan RK; Lavender NA; Sinari S; Chadha M; Liang WS; Kurdoglu A; Izatt T; Christoforides A; Benson H; Phillips L; Baker A; Murray C; Hostetter G; Von Hoff DD; Craig DW; Carpten JD
BMC Med Genomics; 2014 Jun; 7():36. PubMed ID: 24943349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]